Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prelude Therapeutics (PRLD) Asset Utilization Ratio (2025 - 2026)

Prelude Therapeutics' Asset Utilization Ratio history spans 2 years, with the latest figure at 0.13 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio changed N/A to 0.13 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.13, a N/A change, with the full-year FY2025 number at 0.08, up 148.06% from a year prior.
  • Asset Utilization Ratio hit 0.13 in Q1 2026 for Prelude Therapeutics, down from 0.14 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for PRLD hit a ceiling of 0.14 in Q4 2025 and a floor of 0.13 in Q1 2026.